• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Akums Drugs and Pharmaceuticals Limited — Board Meeting, 13-02-2026: Outcome of Board Meeting

    13-02-2026 | 04:03 pm

    Akums Drugs' board approved Q3 & nine-month consolidated results. Q3 revenue hit ₹1,159.59 Cr, profit ₹66.32 Cr. The company noted a ₹12.60 Cr excess IPO expense provision. Strategic expansion includes a new Malta subsidiary for EU pharma marketing.

    No comments yet. Be the first to comment!

    All announcements from Akums Drugs and Pharmaceuticals Limited